SION-719

all catalysts(0)

nothing on the calendar yet

News(5)

• Sionna cystic fibrosis drug fails key trial, removing threat to Vertex
  Sionna’s medicine didn’t have a meaningful additive impact when combined with Vertex’s top-selling Trikafta, surprising analysts and collapsing company shares.
  biopharma_dive · 4d ago
• Sionna’s cystic fibrosis failure is a windfall for Vertex’s blockbuster franchise
  A surprise flop in Phase 2a cystic fibrosis trial sent Sionna’s shares plummeting, but for Vertex, the news reinforced its standard-of-care standing with highly successful drugs like Trikafta.
  biospace · 4d ago
• STAT+: Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial
  A pill from Sionna Therapeutics provided no added benefit when combined with Vertex's cystic fibrosis blockbuster Trikafta, a blow to the biotech.
  stat · 5d ago
• Sionna’s cystic fibrosis flop sends stock down 90%, but a ‘significant positive’ for Vertex
  Sionna Therapeutics has axed a cystic fibrosis add-on program after flunking a phase 2 trial, eliminating a would-be challenger to Vertex Pharmaceuticals’ empire. The biotech plans to “take actions…
  fiercebiotech · 5d ago
• Vertex’s biggest overhang: a rival 50 times smaller
  Despite another strong earnings report, analysts warned that upcoming cystic fibrosis data from Sionna Therapeutics "looms large" over Vertex.
  biopharma_dive · 10d ago